Surreal digital illustration of renal myxoma.

Rare Renal Myxoma: A Medical Mystery Unveiled

Samir D’Costa in Health & Wellness October 2026 • 4 min read.

"Exploring the unusual case of renal myxoma, its diagnosis, and treatment options for this uncommon tumor."

Myxoma, a rare benign tumor, commonly develops in various parts of the body like the skin, bones, and viscera. However, its presence in the kidney is exceedingly rare. When it does occur in the kidney, it typically resides in the parenchyma, with only a few cases involving the capsule.

This article sheds light on an unusual instance of renal myxoma found in a middle-aged man, adding to the limited number of cases documented in English medical literature.

By exploring this case, we aim to educate and inform readers about the nature of renal myxoma, its diagnostic process, and the management strategies employed. Join us as we delve into this medical rarity, offering insights and awareness to healthcare professionals and interested individuals alike.

Unveiling the Case: A Detailed Examination

Surreal digital illustration of renal myxoma.

The patient, a 56-year-old man with a history of hypertension, presented with vague right flank pain and hematuria. Physical examinations did not reveal any significant findings. Initial suspicions leaned toward angiomyolipoma, based on ultrasonography results indicating a hyperechoic mass in the lower pole of the right kidney. However, further investigation was necessary to reach a definitive diagnosis.

Following initial observations, an abdominopelvic CT scan provided more detailed insights, revealing a heterogeneous mass in the lower pole of the right kidney. This mass contained fatty components and showed mild enhancement after contrast administration. A partial nephrectomy was performed, and the subsequent examination revealed a mucoid tumor with a slimy appearance.

The laboratory findings at the time of admission were as follows:

Hemoglobin: 15.9g/dl
White blood cell: 4.6 × 10³/mm³
PLT: 233 × 10³/mm³
International normalized ratio (INR):1
Blood urea nitrogen (BUN):11mg/dl
Creatinine: 1.4 mg/dl
Na:142 mmol/L, K:3.7 mmol/L, PSA:2.45ngr/ml

AI Search Multiple angles on this topic

Latest Research

Recent Evidence on Renal Myxoma

Renal myxoma is described as a very rare benign kidney tumor, with the literature reporting only a small number of cases. One case report concerned a medically free 56-year-old man who had intermittent vague left-sided abdominal pain for one year without gross hematuria or lower urinary tract symptoms. Reviews emphasize recognizing renal myxoma and distinguishing it from other kidney neoplasms with prominent myxoid features.

Counterpoints

Diagnostic Uncertainty

Ultrasonography may be an initial step in detecting a renal mass, but computed tomography and magnetic resonance imaging are recommended for evaluating and managing an unknown renal mass. Because renal myxoma can resemble malignancy on imaging, one reported patient underwent radical nephrectomy after abdominal computed tomography identified a suspected malignant renal mass. Histopathology later revealed the typical appearance of a myxoma, illustrating how diagnostic uncertainty can lead to extensive surgery for a benign tumor.

Microscopic analysis of the tumor cells showed inconspicuous borders and oval nuclei without significant nucleoli or mitotic activity. Immunohistochemistry confirmed the diagnosis as myxoma, with positive vimentin staining and negative results for cytokeratin, desmin, HMB45, S-100, and SMA. The proliferative activity, indicated by Ki-67, was negative. Six months post-diagnosis, the patient remains symptom-free, underscoring the success of the treatment.

Conclusion: Navigating the Landscape of Rare Renal Myxoma

In summary, renal myxoma is a rare benign mesenchymal tumor that requires careful diagnostic evaluation and management. Advanced imaging techniques, such as CT and MRI, play a crucial role in identifying and characterizing these lesions. While nephrectomy has been the standard approach due to malignancy concerns, this case highlights the potential for kidney-sparing approaches when a benign diagnosis is confirmed. Continued research and awareness are essential to optimize outcomes for patients with this rare condition.

AI Search Multiple angles on this topic

Future Outlook

A Technology-Driven Outlook

A May 2026 market outlook projects that the long-term trajectory of the kidney cancer drug market through 2033 will be shaped by technological innovation, personalized medicine, and evolving regulatory landscapes. The source presents these forces as central influences on future development. It does not provide renal-myxoma-specific drug projections.

Broader Context

Pathology and Recognition Challenges

Renal myxoma is a rare benign tumor that can be difficult to distinguish from other neoplasms with prominent myxoid features. In studied cases, tumor cells were positive for vimentin, while s-100 protein, pancytokeratin, and smooth muscle actin were negative in most cases. Imaging may show a large heterogeneous mass that is hyperechoic on ultrasonography and hypodense on computed tomography, contributing to concern about malignancy.

What the tissue findings add up to

The operation was performed with renal cell carcinoma as the preoperative diagnosis, but tissue examination established myxoma instead. This case shows how the final classification depended on pathology rather than the working diagnosis.^[1]

The reported patient and follow-up

Population	A 56-year-old man with renal myxoma^[1]
Duration	Six months of follow-up^[1]
Conflicts of interest	No conflicts of interest declared^[1]
Times cited	6^[1]

How other renal myxoma reports frame this case

The literature review places this report within a small English-language case literature, while another report describes a much larger mass in the upper pole of a different kidney. These cases illustrate variation in reported site and size, not a direct comparison of disease behavior.^{[1] [2]}

A separate MRI case reported a well-defined mass in the left kidney, whereas another account described slight contrast enhancement quantified in Hounsfield units. Those observations belong to separate patients and do not provide a matched imaging comparison with this report.^{[3] [4]}

Later authors describe a gelatinous gross appearance in renal myxoma, consistent with the broader tissue character reported in this literature. A separate cited discussion notes that parenchyma-preserving treatments have been used, but it does not establish comparative outcomes.^{[5] [6]}

Questions left by the renal myxoma reports

How often do renal myxomas arise in the capsule rather than the more usual parenchymal location?^[1]
How consistently do immunohistochemical patterns distinguish myxoma from other tumors with myxoid features across reported cases?^[1]

A brief history of renal myxoma

When was myxoma first reported?

Virchow reported myxoma as a benign mesenchymal mass in 1863; a kidney-capsule case was reported in 1887.^[7]

Terms used in this study

Mesenchymal mass: A benign mass description used in the historical account of myxoma.^[7]
Glycosaminoglycan: A substance associated in the cited accounts with the tumor’s gelatinous gross appearance.^[1]
Myxoid stroma: The tissue background in which spindle-shaped cells are described in the microscopic account.^[1]

Sources

Renal myxoma, a case report and review of the literature (Elsevier BV, 2019)
Renal myxoma – a case report of a rare kidney tumor, its differential diagnosis and literature review (pmc.ncbi.nlm.nih.gov)
Primary renal myxoma: A case report - Turkish Journal of Pathology (turkjpath.org)
Myxoma of the kidney – an unusual benign renal tumor: a case report (pmc.ncbi.nlm.nih.gov)
Renal myxoma: An unforeseen diagnosis. (2020)
Myxoma of the kidney – an unusual benign renal tumor: a case report (2017)
Renal myxoma, a case report and review of the literature (Europe PMC, 2019)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.eucr.2018.11.015, Alternate LINK

Title: Renal Myxoma, A Case Report And Review Of The Literature

Subject: Urology

Journal: Urology Case Reports

Publisher: Elsevier BV

Authors: Mehdi Salehipour, Bita Geramizadeh, Niloofar Dastgheib, Alireza Makarem, Ardalan Asadollah Poor, Negar Taheri

Published: 2019-03-01

Everything You Need To Know

What exactly is a renal myxoma?

A renal myxoma is an exceedingly rare, benign tumor that occurs in the kidney. Myxomas are more commonly found in other parts of the body, such as the skin, bones, and viscera. When found in the kidney, the renal myxoma typically resides in the parenchyma, which is the functional tissue of the organ. Because of its rarity, understanding its characteristics and behavior is crucial for accurate diagnosis and appropriate management.

Why are CT scans and other imaging so important in diagnosing renal myxoma?

Advanced imaging techniques, such as abdominopelvic CT scans and MRI, are vital in detecting and characterizing renal myxomas. In the case discussed, the CT scan revealed a heterogeneous mass in the lower pole of the right kidney, containing fatty components and showing mild enhancement after contrast administration. These imaging details, combined with clinical findings, helped guide the diagnostic process and subsequent treatment decisions. The detail from the scans can direct patient management.

What are the typical treatment options for renal myxoma and why?

The standard treatment for renal myxoma has often been nephrectomy, which involves the surgical removal of the entire kidney. This approach is typically taken due to initial concerns about potential malignancy. However, if a benign diagnosis is confirmed through thorough examination, kidney-sparing approaches, such as a partial nephrectomy, may be considered to preserve kidney function. In the case presented, a partial nephrectomy was performed, and the patient remained symptom-free six months post-diagnosis, highlighting the success of this approach.

How does immunohistochemistry help in diagnosing renal myxoma?

Immunohistochemistry plays a critical role in confirming the diagnosis of renal myxoma. This technique involves staining tumor cells to identify specific proteins. In this case, the tumor cells showed positive staining for vimentin and negative results for cytokeratin, desmin, HMB45, S-100, and SMA. The proliferative activity, indicated by Ki-67, was negative. These specific staining patterns helped confirm the diagnosis as myxoma and rule out other types of tumors.

What kind of symptoms might someone experience with a renal myxoma?

Symptoms of renal myxoma can be vague and non-specific, often leading to initial misdiagnosis. In the case described, the patient presented with right flank pain and hematuria (blood in the urine). Physical examinations did not reveal any significant findings, and initial suspicions leaned toward angiomyolipoma based on ultrasonography results. This highlights the importance of comprehensive evaluation and advanced imaging to accurately diagnose renal myxoma, as the symptoms can mimic other renal conditions.